Are vitiligo treatments cost-effective? A systematic review

Tools

McManus, E. ORCID: https://orcid.org/0000-0002-3442-8721, Sach, T. ORCID: https://orcid.org/0000-0002-8098-9220 and Levell, N. J. ORCID: https://orcid.org/0000-0003-3393-8305 (2018) Are vitiligo treatments cost-effective? A systematic review. British Journal of Dermatology, 178 (1). e57–e58. ISSN 0007-0963

Preview

PDF (Accepted manuscript) - Accepted Version
Download (413kB) | Preview

Abstract

Vitiligo is characterised by well demarcated, cutaneous, macular depigmentation, with worldwide prevalence estimated to be between 0.2-1.8% [1]. Vitiligo treatments aim to encourage re-pigmentation and include topical corticosteroids, calcineurin inhibitors and NB-UVB phototherapy. Camouflage can also be prescribed to help mask the appearance of vitiligo, although this is frequently only prescribed for the face.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:	http://doi.wiley.com/10.1111/bjd.15881
Depositing User:	Pure Connector
Date Deposited:	15 Aug 2017 05:06
Last Modified:	22 Oct 2022 02:59
URI:	https://ueaeprints.uea.ac.uk/id/eprint/64481
DOI:	10.1111/bjd.15881

Actions (login required)

View Item